Celltech Group

Former type	Public
Fate	Acquired
Successor	UCB
Founded	1980
Defunct	2004
Headquarters	Slough, UK
Key people	Goran Ando (CEO)
Industry	Biotechnology

Celltech Group plc was a leading British-based biotechnology business based in Slough. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index.

[edit] History

The Company was founded by Gerard Fairtlough in 1980 with finance from the National Enterprise Board.^[1]

In 1999 the Company led consolidation in the UK biosciences market merging with Chiroscience plc and then buying Medeva plc.^[2] Then in 2000 it bought Cistron, a US biosciences business.^[3]

It expanded into Germany in 2001 buying Thiemann, a German biosciences business.^[4]

In 2003 it acquired Oxford Glycosciences, a rival British biosciences business.^[5] It was acquired by UCB, a Belgian drugmaker, in 2004.^[6] Since then it has been known as UCB Celltech.

[edit] Operations

The Company was engaged in research and development of therapies for patients with serious diseases. Products included:^[7]

• Tussionex for coughs
• Zaroxolyn for resistant edema
• Metadate for ADHD
• Methylphenidate for ADHD
• Sempex-D, an antihistamine and decongestant

[edit] References